Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1980 2
1982 2
1992 1
1993 1
1996 1
1998 1
1999 1
2000 4
2002 1
2003 3
2004 6
2005 4
2006 3
2007 1
2008 6
2009 2
2010 3
2011 5
2012 3
2013 6
2014 4
2015 7
2016 8
2017 11
2018 14
2019 11
2020 16
2021 7
2022 8
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.
Naccache JM, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A, Reynaud-Gaubert M, Bonniaud P, Israël-Biet D, Prévot G, Hirschi S, Lebargy F, Marchand-Adam S, Bautin N, Traclet J, Gomez E, Leroy S, Gagnadoux F, Rivière F, Bergot E, Gondouin A, Blanchard E, Parrot A, Blanc FX, Chabrol A, Dominique S, Gibelin A, Tazi A, Berard L, Brillet PY, Debray MP, Rousseau A, Kerjouan M, Freynet O, Dombret MC, Gamez AS, Nieves A, Beltramo G, Pastré J, Le Borgne-Krams A, Dégot T, Launois C, Plantier L, Wémeau-Stervinou L, Cadranel J, Chenivesse C, Valeyre D, Crestani B, Cottin V, Simon T, Nunes H; EXAFIP investigators and the OrphaLung network. Naccache JM, et al. Among authors: gamez as. Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7. Lancet Respir Med. 2022. PMID: 34506761 Clinical Trial.
New and potential strategies for the treatment of PMM2-CDG.
Gámez A, Serrano M, Gallego D, Vilas A, Pérez B. Gámez A, et al. Biochim Biophys Acta Gen Subj. 2020 Nov;1864(11):129686. doi: 10.1016/j.bbagen.2020.129686. Epub 2020 Jul 23. Biochim Biophys Acta Gen Subj. 2020. PMID: 32712172 Review.
Protein misfolding diseases: Prospects of pharmacological treatment.
Gámez A, Yuste-Checa P, Brasil S, Briso-Montiano Á, Desviat LR, Ugarte M, Pérez-Cerdá C, Pérez B. Gámez A, et al. Clin Genet. 2018 Mar;93(3):450-458. doi: 10.1111/cge.13088. Epub 2017 Dec 4. Clin Genet. 2018. PMID: 28671287 Review.
LAM is another small airway disease: lessons from microCT.
Bourdin A, Gamez AS, Vachier I, Crestani B. Bourdin A, et al. Among authors: gamez as. Eur Respir J. 2020 Jul 2;56(1):2002162. doi: 10.1183/13993003.02162-2020. Print 2020 Jul. Eur Respir J. 2020. PMID: 32616551 Free article. No abstract available.
Pharmacological Chaperoning: A Potential Treatment for PMM2-CDG.
Yuste-Checa P, Brasil S, Gámez A, Underhaug J, Desviat LR, Ugarte M, Pérez-Cerdá C, Martinez A, Pérez B. Yuste-Checa P, et al. Among authors: gamez a. Hum Mutat. 2017 Feb;38(2):160-168. doi: 10.1002/humu.23138. Epub 2016 Nov 21. Hum Mutat. 2017. PMID: 27774737
Future treatment for asthma.
Charriot J, Vachier I, Halimi L, Gamez AS, Boissin C, Salama M, Cucu-Jarjour A, Ahmed E, Bourdin A. Charriot J, et al. Among authors: gamez as. Eur Respir Rev. 2016 Mar;25(139):77-92. doi: 10.1183/16000617.0069-2015. Eur Respir Rev. 2016. PMID: 26929425 Free PMC article.
Antisense-mediated therapeutic pseudoexon skipping in TMEM165-CDG.
Yuste-Checa P, Medrano C, Gámez A, Desviat LR, Matthijs G, Ugarte M, Pérez-Cerdá C, Pérez B. Yuste-Checa P, et al. Among authors: gamez a. Clin Genet. 2015;87(1):42-8. doi: 10.1111/cge.12402. Epub 2014 May 22. Clin Genet. 2015. PMID: 24720419
135 results